减少牙龈炎对肺功能的影响:强化口腔卫生下的随机试验
该随机试验计划纳入120名18至30岁非吸烟的菌斑生物膜诱导牙龈炎受试者,采用等待对照组设计比较即刻干预与延迟干预,干预包括专业洁牙、含氯己定(CHX)的一阶段全口消毒和优化日常口腔卫生。主要检验牙龈炎减少使用力肺活量(FVC)改善至少2%的假设,次要检验第一秒用力呼气容积(FEV1)和用力呼气流速25-75%(FEF25-75)改善至少2%,并考虑口腔微生物组的影响。
要点
- 纳入120名18至30岁非吸烟菌斑生物膜诱导牙龈炎受试者,采用等待对照组设计。
- 干预为专业洁牙、含CHX一阶段全口消毒及优化日常口腔卫生。
- 主要结局为FVC改善至少2%,次要结局为FEV1和FEF25-75改善至少2%。
核心结论
- 该干预性试验主要检验通过优化日常口腔卫生、专业洁牙和含氯己定(CHX)抗菌漱口水减少牙龈炎可使用力肺活量(FVC)改善至少2%的假设。
- 次要目的检验牙龈炎减少使第一秒用力呼气容积(FEV1)和用力呼气流速25-75%(FEF25-75)改善至少2%的假设。
- 研究还将考虑口腔微生物组的影响。
研究设计与样本
- 随机试验,采用等待对照组设计,比较即刻干预组与作为对照的延迟干预组。
- 计划纳入120名18至30岁非吸烟、菌斑生物膜诱导牙龈炎受试者。
- 记录牙科和牙龈状态、肺功能及口腔微生物组。
关键数值与推荐
- 主要结局指标为用力肺活量(FVC)改善至少2%。
- 次要结局指标为第一秒用力呼气容积(FEV1)和用力呼气流速25-75%(FEF25-75)改善至少2%。
- 近期观察性研究显示,非吸烟者中严重牙龈炎与肺容积和流量显著降低71-185 ml相关,校正潜在混杂因素后仍存在。
- 该观察性结果未显示吸烟混杂,牙龈炎与较低肺功能的关联未受全身性炎症修饰。
局限性
- 强化预防干预(专业洁牙、含CHX一阶段全口消毒及确保受试者优化日常口腔卫生)无法设盲,但肺功能测试的结局测量为盲法。
- 此前仅有一项针对严重牙周炎患者(多为吸烟者)的干预研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periodontal disease and lung function impairment were found to be associated with low-grade systemic or local inflammation, and it might be that gingival/periodontal inflammation triggers lung function due to systemic inflammation or the transfer of oral bacteria or its components to the lung. A recent observational study in non-smoking subjects showed that lung volumes and flow rates were significantly reduced by 71-185 ml for severe gingivitis regardless of the adjustment for potential confounders. The result did not show any confounding by smoking, and the association between gingivitis and lower lung function was not modified by systemic inflammation. The designed interventional trial primarily aims to test the hypothesis that gingivitis reduction by optimized daily oral hygiene, professional tooth cleaning and antibacterial chlorhexidine (CHX)-containing mouth rinse improves lung function in terms of forced vital capacity (FVC) by at least 2%. The secondary objective will test the hypothesis that gingivitis reduction improves forced expiratory volume in 1 s (FEV1) and forced expiratory flow at 25-75% of the pulmonary volume (FEF25-75) by at least 2%. Furthermore, the influence of the oral microbiome will be taken into account. METHODS: The study has to include 120 non-smoking subjects aged between 18 and 30 years with biofilm-induced gingivitis. The chosen "waiting control group design" will compare the immediate intervention group with the delayed intervention group, which serves as a control group. Dental and gingival status, lung function and oral microbiome will be recorded. The intensified preventive intervention-professional tooth cleaning, one-stage full-mouth disinfection with CHX and safeguarding an optimal daily oral hygiene by each subject-cannot be blinded, but the outcome measurement in terms of lung function tests is blind. DISCUSSION: This proposed multidisciplinary study has several strengths. Only one previous intervention study with patients with severe periodontitis (mostly smokers) has been performed. It is novel to include non-smoking subjects with mild and potentially reversible oral inflammation. Furthermore, this research is innovative, because it includes evidence-based interventions for gingivitis reduction, standardized measures of the outcome on lung function and oral microbiome and combines expertise from dentistry, lung physiology, oral microbiology and epidemiology/statistical modelling. TRIAL REGISTRATION: German Clinical Trial Register DRKS00028176. Registered on February 2022.
引用
- Kühnisch J, Zhao T, Bertelsen RJ, et al. The impact of gingivitis reduction on lung function: a randomized trial under intensified oral hygiene. Trials. 2023. PMID: 36823669. doi:10.1186/s13063-023-07135-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。